• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER, LTD (HAIFA, ISRAEL) CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER, LTD (HAIFA, ISRAEL) CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Model Number M-4800-01
Device Problem Radio Signal Problem (1511)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/31/2013
Event Type  malfunction  
Event Description
It was reported that during the atrial flutter right (r-afl) procedure, while pacing from 20b, they lost all body surface (bs) and intracardiac (ic) egms on both the carto 3 system and on the recording system.It was also reported that during the same procedure, they lost all bs and ic egms on both the carto 3 system and on the recording system intermittently when they were pacing from ref/deca and only during ablation.There was no patient injury reported.Upon request, additional information was provided on the event.It was planned pacing.The signal loss was mainly on the 12 leads.The signal loss was on both the carto 3 system and the recording system at the same time.The physician did not have any signals available to monitor the heart rhythm.The signal loss occurred during ablation and pacing.The procedure was able to be completed.Per the event stating the loss of all signals ic and bs on both the carto 3 system and the recording system at the same time is indicative of a reportable event.
 
Manufacturer Narrative
Investigation still in progress.A supplemental report or device evaluation will be submitted.(b)(4).
 
Manufacturer Narrative
(b)(4).It was reported that during the atrial flutter right (r-afl) procedure, while pacing from 20b, they lost all body surface (bs) and intracardiac (ic) egms on both the carto 3 system and on the recording system.It was also reported that during the same procedure, they lost all bs and ic egms on both the carto 3 system and on the recording system intermittently when they were pacing from ref/deca and only during ablation.There was no patient injury reported.The bwi field service engineer first performed the ecg modular atp and the pacing test failed.He then reseated the ecg cards and tested it again which resulted in the test passing.Reseating the ecg cards resolved the issue.The system is ready for use.An additional oem manufacturer action device history record (dhr) review was performed.No anomalies were noted in manufacturing or service.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO® 3 SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER, LTD (HAIFA, ISRAEL)
4 hatnufah st.
yokneam 20692
IS  20692
Manufacturer (Section G)
BIOSENSE WEBSTER, LTD (HAIFA, ISRAEL)
4 hatnufah st.
yokneam 2069 2
IS   20692
Manufacturer Contact
jaime chavez
15715 arrow highway
irwindale, CA 91706
9098398483
MDR Report Key3778666
MDR Text Key15806400
Report Number3008203003-2014-00033
Device Sequence Number1
Product Code DQK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K090017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/31/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM-4800-01
Device Catalogue NumberFG540000
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/31/2014
Initial Date FDA Received04/29/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/21/2014
Was Device Evaluated by Manufacturer? Yes
Type of Device Usage Reuse
Patient Sequence Number1
-
-